CN1699562A - Method for separation and purification of gene recombinant protein heme oxygenase - Google Patents
Method for separation and purification of gene recombinant protein heme oxygenase Download PDFInfo
- Publication number
- CN1699562A CN1699562A CN 200510026385 CN200510026385A CN1699562A CN 1699562 A CN1699562 A CN 1699562A CN 200510026385 CN200510026385 CN 200510026385 CN 200510026385 A CN200510026385 A CN 200510026385A CN 1699562 A CN1699562 A CN 1699562A
- Authority
- CN
- China
- Prior art keywords
- heme oxygenase
- recombinant protein
- separation
- purification
- expanded bed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
The invention relates to a process for separation and purification of gene recombinant protein heme oxygenase, which comprises subjecting the expression recombination protoheme oxygenase-1 fermentation liquor to centrifugal collection of cells, ultrasonic wave fragmenting, expanded-bed ion exchange chromatography and gel filtration chromatography for purification preparation. Compared with the existing separation process, provided method has the advantages of substantially reduced time of separation process and increased yield of recombination human heme oxygenase-1.
Description
Technical field
What the present invention relates to is the method for a kind of preparation method's of technical field of bioengineering, particularly a kind of gene recombinant protein heme oxygenase separation and purification.
Background technology
Heme oxygenase (Heme Oxygenase, HO) be middle existence the in the mammalian body, oxydase with multiple function relevant with the heme metabolism, it makes the methyl bridge cracking on the protoheme tetrapyrrole ring, finally forms the uteroverdine and the CO of equivalent and discharges iron atom.The eighties in last century middle and advanced stage, Maines etc. take the lead in, and separation and purification obtains in tissue such as the liver of animal and human's body, spleen, lung, brain and testis.So far; obtain three kinds of HO isozyme: HO-1, HO-2 and HO-3 in human and Mammals, HO-1 is induction type HO, as a kind of stress protein; under the condition that some hostile environments stimulate and disease exists, can play the certain protection effect to body, tissue.HO-1 can play the protection transplant organ and reduce the injury that rejection brings in the organ transplantation process, showing good application prospects aspect the pedicterus treatment simultaneously.In general, in actual production, generally need steps such as cytoclasis, centrifugal settling, salt precipitation, anion-exchange chromatography, cation-exchange chromatography and gel permeation chromatography to obtaining highly purified heme oxygenase from lysis.Product yield that various separating step causes low (common product yield about 10%) and production cycle are long, become the bottleneck problem of whole process of production.Therefore, selecting fast and effectively, separation means is the key that addresses the above problem.In recent years, the proposition of integrated isolation technique notion is that bioseparation technology has been opened up new field, and becomes the new focus in the bioseparation technology research gradually, and the expanded bed adsorption technology is exactly one of them.Expanded bed is liquid-solid fluid bed that the solids fluidisation is in stable condition, the back-mixing degree is very little.The expanded bed adsorption technology can be from the coarse fodder liquid that contains cell and cell debris direct Separation and Recovery target product, and save steps such as centrifugal, filtration.
Find by prior art documents, have not yet to see relevant expanded bed technology and be used for the recombinate method of heme oxygenase-1 of separation and purification people.The expanded bed technology is applied to the purge process of recombinant human heme oxygenase-1, can replace the existing purge process that comprises based on centrifugal settling, salt precipitation, hydrophobic interaction chromatography, anion-exchange chromatography, cation-exchange chromatography and gel permeation chromatography, thereby shorten the purifying time greatly, improve the product activity yield, cut down the consumption of energy.
Summary of the invention
The objective of the invention is to overcome deficiency of the prior art, a kind of method of separation and purification of gene recombinant protein heme oxygenase is provided.Make that its method is simple, the cycle is short, the product activity recovery is high is the method for main means with expanded bed.
The present invention is achieved by the following technical solutions, and the present invention carries out the purifying preparation with the fermented liquid of express recombinant heme oxygenase-1 through centrifugal collecting cell, ultrasonic disruption, expanded bed ion exchange chromatography and gel permeation chromatography.
Comprise that step is as follows:
1. expanded bed ion exchange chromatography
With refrigerated centrifuge with the centrifugal 15min of fermented liquid, collecting cell, again suspend with damping fluid, with ultrasonic disruption instrument smudge cells, after cytoclasis liquid dilutes 2~6 times with damping fluid, the expansion column is earlier with Tris-HCl damping fluid balance, feed the fermented liquid that has diluted from the expanded bed bottom then, carry out adsorption operations, damping fluid cleans 1~5 column volume under the expanded bed state, remove foreign protein and cell debris solid substance, at the fixed bed operation state with containing 1mol/L NaCl buffer solution for gradient elution, collect active peak, wash-out finishes when the chromatographic peak response value reaches baseline position.
Step 1. in:
Described fermented liquid is centrifugal under 4 ℃ of conditions, and centrifugal speed is 4000rpm.
Described damping fluid is: 0.001~0.05mol/L pH7.0~9.0.
Described sodium phosphate salt damping fluid is at 20~30 ℃, feeds the fermented liquid that has diluted with the flow velocity of 100~300cm/h from the expanded bed bottom.
Described expanded bed is controlled its bed expansion ratio and is 1.5~3.0 and carries out adsorption operations.
Described damping fluid cleans under the expanded bed state with the flow velocity of 100~300cm/h.
2. gel permeation chromatography
Top elutriant is joined in the Sephacryl S-200 gel chromatography column, finish to going out the peak, collect active peak, preserve after the lyophilize with the phosphate buffered saline buffer washing.
Step 2. in:
Described elutriant adds with the flow velocity of 10~50cm/h.
Described phosphate buffered saline buffer, for: 0.001~0.05mol/L pH6.0~8.0.
Described phosphate buffered saline buffer finishes to going out the peak with the washing of the flow velocity of 10~50cm/h.
Purifying Heme Oxygenase-1's of the present invention process is compared with existing separation method, its tangible advantage is: after the somatic cells fragmentation, need not centrifugal at low temperatures, saltout, dissolution precipitation and the dissolving after centrifugal process, be directly used in the expanded bed adsorption chromatographic separation after can suitably diluting, shortened the time of sepn process greatly, improve the yield of recombinant human heme oxygenase-1 significantly, and reduced energy consumption.This technology has broad application prospects in the purge process of recombinant human heme oxygenase-1.
Embodiment
Below in conjunction with specific embodiment technical scheme of the present invention is elaborated
Embodiment 1
With refrigerated centrifuge with fermented liquid under 4 ℃ of conditions with the centrifugal 15min of the speed of 4000rpm, collecting cell suspends again with the Tris-HCl damping fluid of 0.005mol/L pH7.0, with ultrasonic disruption instrument smudge cells.Cytoclasis liquid dilutes 2 times with the Tris-HCl damping fluid of 0.005mol/L pH7.0.StreamlineDEAE is filled in XK 26 chromatographic columns, and packing height is 11cm.Fluid distributor on the chromatographic column is adjusted to the 22.5cm place, fixing.Feed the Tris-HCl damping fluid of 0.005mol/L pH7.0 from the chromatographic column bottom, make 2 times of bed expansions, balance 30min.With diluted stock liquid feed from the chromatographic column bottom, regulate the flow velocity of feed liquid, the ratio of expansion of keeping expanded bed is constant, collects simultaneously from the effusive solution of chromatographic column.Behind the last sample, keep rate of expansion constant, feed the Tris-HCl damping fluid of 0.005mol/L pH7.0, clean 2~3 column volumes, collect the effusive solution of wash phase chromatographic column.To go up fluid distributor and reduce to the 11.5cm place, adopt the fixed bed operation mode, flow velocity with 60cm/h carries out gradient elution from the Tris-HCl damping fluid that the feeding of chromatographic column top contains the 0.005mol/LpH7.0 of 1mol/L NaCl, collect active peak, wash-out finishes when the chromatographic peak response value reaches baseline position.
The flow velocity of top elutriant with 40cm/h joined in the Sephacryl S-200 gel chromatography column, finish to going out the peak with the flow velocity washing identical, collect active peak, preserve after the lyophilize with sample introduction with the phosphate buffered saline buffer of 0.02mol/L pH7.5.
Embodiment 2
With refrigerated centrifuge with fermented liquid under 4 ℃ of conditions with the centrifugal 15min of the speed of 4000rpm, collecting cell suspends again with the Tris-HCl damping fluid of 0.01mol/L pH8.0, with ultrasonic disruption instrument smudge cells.Cytoclasis liquid dilutes 3 times with the Tris-HCl damping fluid of 0.01mol/L pH8.0.StreamlineDEAE is filled in XK 26 chromatographic columns, and packing height is 11cm.Fluid distributor on the chromatographic column is adjusted to the 28cm place, fixing.Feed the Tris-HCl damping fluid of 0.01mol/L pH8.0 from the chromatographic column bottom, make 2.5 times of bed expansions, balance 30min.With diluted stock liquid feed from the chromatographic column bottom, regulate the flow velocity of feed liquid, the ratio of expansion of keeping expanded bed is constant, collects simultaneously from the effusive solution of chromatographic column.Behind the last sample, keep rate of expansion constant, feed the Tris-HCl damping fluid of 0.01mol/L pH8.0, clean 3~4 column volumes, collect the effusive solution of wash phase chromatographic column.To go up fluid distributor and reduce to the 11.5cm place, adopt the fixed bed operation mode, flow velocity with 60cm/h carries out gradient elution from the Tris-HCl damping fluid that the feeding of chromatographic column top contains the 0.01mol/LpH8.0 of 1mol/L NaCl, collect active peak, wash-out finishes when the chromatographic peak response value reaches baseline position.
The flow velocity of top elutriant with 20cm/h joined in the Sephacryl S-200 gel chromatography column, finish to going out the peak with the flow velocity washing identical, collect active peak, preserve after the lyophilize with sample introduction with the phosphate buffered saline buffer of 0.05mol/L pH7.0.
Embodiment 3
With refrigerated centrifuge with fermented liquid under 4 ℃ of conditions with the centrifugal 15min of the speed of 4000rpm, collecting cell suspends again with the Tris-HCl damping fluid of 0.02mol/L pH8.5, with ultrasonic disruption instrument smudge cells.Cytoclasis liquid dilutes 2 times with the Tris-HCl damping fluid of 0.02mol/L pH 8.5.StreamlineDEAE is filled in XK 26 chromatographic columns, and packing height is 11cm.Fluid distributor on the chromatographic column is adjusted to the 28cm place, fixing.Feed the Tris-HCl damping fluid of 0.02mol/L pH8.5 from the chromatographic column bottom, make 2.5 times of bed expansions, balance 30min.With diluted stock liquid feed from the chromatographic column bottom, regulate the flow velocity of feed liquid, the ratio of expansion of keeping expanded bed is constant, collects simultaneously from the effusive solution of chromatographic column.Behind the last sample, keep rate of expansion constant, feed the Tris-HCl damping fluid of 0.02mol/L pH8.5, clean 3~4 column volumes, collect the effusive solution of wash phase chromatographic column.To go up fluid distributor and reduce to the 11.5cm place, adopt the fixed bed operation mode, flow velocity with 60cm/h carries out gradient elution from the Tris-HCl damping fluid that the feeding of chromatographic column top contains the 0.02mol/LpH8.5 of 1mol/L NaCl, collect active peak, wash-out finishes when the chromatographic peak response value reaches baseline position.
The flow velocity of top elutriant with 40cm/h joined in the Sephacryl S-200 gel chromatography column, finish to going out the peak with the flow velocity washing identical, collect active peak, preserve after the lyophilize with sample introduction with the phosphate buffered saline buffer of 0.02mol/L pH7.5.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510026385 CN1289666C (en) | 2005-06-02 | 2005-06-02 | Process for separation and purification of gene recombinant protein heme oxygenase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510026385 CN1289666C (en) | 2005-06-02 | 2005-06-02 | Process for separation and purification of gene recombinant protein heme oxygenase |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1699562A true CN1699562A (en) | 2005-11-23 |
CN1289666C CN1289666C (en) | 2006-12-13 |
Family
ID=35475809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510026385 Expired - Fee Related CN1289666C (en) | 2005-06-02 | 2005-06-02 | Process for separation and purification of gene recombinant protein heme oxygenase |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1289666C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101870981A (en) * | 2010-05-28 | 2010-10-27 | 中国人民解放军军事医学科学院野战输血研究所 | Expression and purification method of heme oxygenase-1, and epitopes thereof |
CN105727379A (en) * | 2016-02-25 | 2016-07-06 | 顾宇春 | Haem oxygenase drug eluting stent |
CN107937420A (en) * | 2017-12-20 | 2018-04-20 | 陈如凯 | The HMOX1 mutators and its application that 127th site is undergone mutation |
CN107937421A (en) * | 2017-12-20 | 2018-04-20 | 陈如凯 | The HMOX1 mutators and its application that 111st site is undergone mutation |
-
2005
- 2005-06-02 CN CN 200510026385 patent/CN1289666C/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101870981A (en) * | 2010-05-28 | 2010-10-27 | 中国人民解放军军事医学科学院野战输血研究所 | Expression and purification method of heme oxygenase-1, and epitopes thereof |
CN105727379A (en) * | 2016-02-25 | 2016-07-06 | 顾宇春 | Haem oxygenase drug eluting stent |
CN107937420A (en) * | 2017-12-20 | 2018-04-20 | 陈如凯 | The HMOX1 mutators and its application that 127th site is undergone mutation |
CN107937421A (en) * | 2017-12-20 | 2018-04-20 | 陈如凯 | The HMOX1 mutators and its application that 111st site is undergone mutation |
Also Published As
Publication number | Publication date |
---|---|
CN1289666C (en) | 2006-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104774182B (en) | The extraction of erythrothioneine and purification process | |
CN101638427B (en) | A kind of purification method of virus antigen | |
TWI748411B (en) | Method of purifying botulinum toxin | |
CN102329381A (en) | Method for simultaneously separating high-purity phycocyanin and allophycocyanin and application thereof | |
Li et al. | Enzyme-assisted extraction of naphthodianthrones from Hypericum perforatum L. by 12C6+-ion beam-improved cellulases | |
TWI797442B (en) | Method of purifying botulinum toxin | |
CN1699562A (en) | Method for separation and purification of gene recombinant protein heme oxygenase | |
CN110951814B (en) | Method for preparing prostaglandin E1 using genetically engineered cyclooxygenase-1 and genetically engineered prostaglandin E synthase-1 | |
KR910008643B1 (en) | Method for Purifying Hepatitis B Virus Surface Antigen (HBs Antigen) | |
CN101367865B (en) | Production process for high purity porcine blood albumin and uses thereof | |
CN107033237A (en) | A kind of Human Plasma Apolipoprotein A I isolation and purification method | |
CN115948351B (en) | Method for separating and purifying CVB1 | |
CN103694367B (en) | A kind of extraction and application method with anti-oxidant activity clam polysaccharide | |
CN102924586A (en) | Method for producing pregnant mare serum gonactotropin by monoclonal antibody technology | |
EP4299580A1 (en) | High-yield purification method for target protein | |
CN103102252B (en) | A method for separating and purifying (+)-isolaricoresinol and (-)-larixin from Folium chinensis | |
CN110468172A (en) | A kind of method and kit isolating and purifying recombination LEA protein | |
CN107446905B (en) | Method for purifying recombinant human lysozyme | |
CN102321150B (en) | A method for isolating recombinant human antibody from mammary gland bioreactor expression product | |
CN114591926A (en) | Purification method of human respiratory chain compound I | |
CN1563400A (en) | Method for separating and preparing prodigiosin | |
CN103044510B (en) | The isolation technique of ergosterol in Phellinus bacterium | |
CN107418945B (en) | A method for separating and purifying Fusarium thaliana to obtain β-glucosidase | |
RU2434018C2 (en) | Method of obtaining and purifying human inhibin-a | |
CN102516381B (en) | Natural sex storage protein-2 as well as preparation and use for same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20061213 |